Re-treatment Safety of Radium-223 Dichloride in Castration-resistant Prostate Cancer With Bone Metastases
Condition(s):Prostatic NeoplasmsLast Updated:March 26, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Prostatic NeoplasmsLast Updated:March 26, 2018Completed
Condition(s):Prostate Cancer Metastatic to BoneLast Updated:November 17, 2020Active, not recruiting
Condition(s):Prostate CancerLast Updated:February 1, 2018Completed
Condition(s):Prostatic NeoplasmsLast Updated:September 19, 2018Completed
Condition(s):Neoplasms; Bone DiseasesLast Updated:November 30, 2016Completed
Condition(s):Bony Metastases From Castrate Refractory Prostate CancerLast Updated:June 11, 2019Completed
Condition(s):Breast NeoplasmsLast Updated:August 10, 2020Terminated
Condition(s):Advanced Renal Cell Carcinoma; Chromophobe Renal Cell Carcinoma; Clear Cell Renal Cell Carcinoma; Collecting Duct Carcinoma; Kidney Medullary Carcinoma; Metastatic Malignant Neoplasm in the Bone; Papillary Renal Cell Carcinoma; Stage IV Renal Cell Cancer AJCC v8; Unclassified Renal Cell CarcinomaLast Updated:March 26, 2024Recruiting
Condition(s):Prostate AdenocarcinomaLast Updated:November 22, 2023Active, not recruiting
Condition(s):Castration-resistant Prostate CancerLast Updated:March 15, 2024Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.